A new trading day began on Friday, with Collegium Pharmaceutical Inc (NASDAQ: COLL) stock price up 6.61% from the previous day of trading, before settling in for the closing price of $24.67. COLL’s price has ranged from $23.23 to $42.29 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 18.99% over the last five years. Meanwhile, its annual earnings per share averaged 28.84%. With a float of $30.91 million, this company’s outstanding shares have now reached $31.44 million.
The firm has a total of 357 workers. Let’s measure their productivity. In terms of profitability, gross margin is 59.76%, operating margin of 26.91%, and the pretax margin is 15.61%.
Collegium Pharmaceutical Inc (COLL) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Collegium Pharmaceutical Inc is 3.81%, while institutional ownership is 117.40%. The most recent insider transaction that took place on Mar 21 ’25, was worth 192,069. In this transaction EVP & Chief Financial Officer of this company sold 6,396 shares at a rate of $30.03, taking the stock ownership to the 156,667 shares. Before that another transaction happened on Mar 20 ’25, when Company’s EVP & Chief Financial Officer sold 1,206 for $30.00, making the entire transaction worth $36,181. This insider now owns 163,063 shares in total.
Collegium Pharmaceutical Inc (COLL) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.63 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 28.84% per share during the next fiscal year.
Collegium Pharmaceutical Inc (NASDAQ: COLL) Trading Performance Indicators
Here are Collegium Pharmaceutical Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.88. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.34. Likewise, its price to free cash flow for the trailing twelve months is 4.16.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.85, a number that is poised to hit 1.79 in the next quarter and is forecasted to reach 8.59 in one year’s time.
Technical Analysis of Collegium Pharmaceutical Inc (COLL)
Analysing the last 5-days average volume posted by the [Collegium Pharmaceutical Inc, COLL], we can find that recorded value of 0.58 million was better than the volume posted last year of 0.42 million. As of the previous 9 days, the stock’s Stochastic %D was 31.55%. Additionally, its Average True Range was 1.47.
During the past 100 days, Collegium Pharmaceutical Inc’s (COLL) raw stochastic average was set at 28.33%, which indicates a significant decrease from 42.08% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 56.18% in the past 14 days, which was higher than the 41.37% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $29.39, while its 200-day Moving Average is $32.88. Now, the first resistance to watch is $26.94. This is followed by the second major resistance level at $27.57. The third major resistance level sits at $28.81. If the price goes on to break the first support level at $25.07, it is likely to go to the next support level at $23.83. Now, if the price goes above the second support level, the third support stands at $23.20.
Collegium Pharmaceutical Inc (NASDAQ: COLL) Key Stats
With a market capitalization of 845.02 million, the company has a total of 32,132K Shares Outstanding. Currently, annual sales are 631,450 K while annual income is 69,190 K. The company’s previous quarter sales were 181,950 K while its latest quarter income was 12,540 K.
